168 related articles for article (PubMed ID: 38434899)
1. Synthesis, Anticancer Activity, and
Abbade Y; Kisla MM; Hassan MA; Celik I; Dogan TS; Mutlu P; Ates-Alagoz Z
ACS Omega; 2024 Feb; 9(8):9547-9563. PubMed ID: 38434899
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
5. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
6. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
8. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
9. Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and
Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):86-99. PubMed ID: 34894963
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold.
Abdelgawad MA; Hayallah AM; Bukhari SNA; Musa A; Elmowafy M; Abdel-Rahman HM; Abd El-Gaber MK
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422546
[TBL] [Abstract][Full Text] [Related]
11.
Almansour NM; Allemailem KS; Abd El Aty AA; Ismail EIF; Ibrahim MAA
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677841
[TBL] [Abstract][Full Text] [Related]
12. Design, in silico study, synthesis and in vitro evaluation of some N5-(1H-pyrazol-3-yl)-3H-benzo[d]imidazole-2,5-diamine derivatives as potential pancreatic lipase inhibitors for anti-obesity activity.
Unnisa A; Huwaimel B; Almahmoud S; Abouzied AS; Younes KM; Anupama B; Kola PK; Lakshmi NVKC
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7245-7255. PubMed ID: 36263535
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of benzimidazole derivatives as apoptosis-inducing agents by targeting Bcl-2 protein.
Ilhan S; Çamli Pulat Ç; Oguz F; Bektaş H; Menteşe E; Atmaca H
Mol Divers; 2023 Aug; 27(4):1703-1712. PubMed ID: 36065037
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners.
Abouelenein MG; El-Rashedy AA; Awad HM; El Farargy AF; Nassar IF; Nassrallah A
Bioorg Chem; 2023 Dec; 141():106910. PubMed ID: 37871393
[TBL] [Abstract][Full Text] [Related]
15. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
[TBL] [Abstract][Full Text] [Related]
16. New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies.
Al-Tuwaijri HM; Al-Abdullah ES; El-Rashedy AA; Ansari SA; Almomen A; Alshibl HM; Haiba ME; Alkahtani HM
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175074
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies.
Hammouda MM; Elmaaty AA; Nafie MS; Abdel-Motaal M; Mohamed NS; Tantawy MA; Belal A; Alnajjar R; Eldehna WM; Al-Karmalawy AA
Bioorg Chem; 2022 Oct; 127():105995. PubMed ID: 35792315
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
19. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
Beygi F; Mostoufi A; Mojaddami A
Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
[TBL] [Abstract][Full Text] [Related]
20. New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies.
Nashaat S; Henen MA; El-Messery SM; Eisa H
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]